McManus Matthew 4
4 · BIO-TECHNE Corp · Filed Feb 5, 2024
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
McManus Matthew
President - Diag & Spatial Bio
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+7,951→ 7,951 totalExercise: $68.54Exp: 2031-02-01→ Common Stock (7,951 underlying) - Award
Restricted Stock Units
2024-02-01+2,888→ 2,888 total→ Common Stock (2,888 underlying) - Award
Restricted Stock Units
2024-02-01+13,861→ 13,861 total→ Common Stock (13,861 underlying) - Award
Stock Option (Right to Buy)
2024-02-01+15,902→ 15,902 totalExercise: $68.54Exp: 2031-02-01→ Common Stock (15,902 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F2]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F3]4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.
- [F4]Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.